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for gaining insights into virus–host interactions. Sequencing
assays can discover novel viruses and describe the genomes
of novel and known viruses. Genomic information can predict
viral proteins that can be characterized, describe important
genes in the host that control infections, and evaluate gene
expression of viruses and hosts during infection. Sequencing
can also describe variation and evolution of viruses during
replication and transmission. This review recounts some of the
major advances in the studies of virus–host interactions from
the last two years, and discusses the uses of sequencing
technologies relating to these studies.
Addresses
1 The Genome Institute, Washington University School of Medicine,
Campus Box 8501, 4444 Forest Park Avenue, St. Louis, MO 63108,
United States
2 The Department of Pediatrics, Washington University School of
Medicine, Campus Box 8116, 660 S. Euclid Avenue, St. Louis, MO
63110, United States
Corresponding author: Wylie, Kristine M (kwylie@genome.wustl.edu)
Current Opinion in Microbiology 2013, 16:479–484
This review comes from a themed issue on Host–microbe
interactions: viruses
Edited by Carlos F Arias
For a complete overview see the Issue and the Editorial
Available online 23rd May 2013
1369-5274# 2013 The Authors. Published by Elsevier Ltd.
http://dx.doi.org/10.1016/j.mib.2013.04.006
Introduction
The dynamic interactions between viruses and their hosts
during infection are complex. Viruses manipulate the
cellular environment and subvert host immune responses
in order to replicate, and the host counters the virus’s
maneuvers in order to control the infection. The interplay
between virus and host can be studied in many ways:
natural infections; model systems (either animal or cell
culture); manipulation of virus–host interactions; identifi-
cation of the proteins involved in virus–host interactions;
and studies of protein functions. High throughput, deep
sequencing is a powerful tool for gaining insights into
virus–host interactions. Sequencing assays can predict
Open access under CC BY license.www.sciencedirect.com novel viruses and describe the genomes of novel and
known viruses. Genomic information can be used to dis-
cover viral proteins that can then be characterized, describe
genes in the host that are important in controlling infec-
tions, and evaluate gene expression of viruses and hosts
during infection. Sequencing can also assess variation and
evolution of viruses during replication and transmission.
This review recounts some of the major advances in the
studies of virus–host interactions from the last two years,
and discusses the uses (or potential uses) of sequencing
technologies relating to these studies (Figure 1).
Virus discovery and emerging pathogens
In order to understand how viruses interact with their
hosts and how they affect human health, we must under-
stand the scope of viral diversity and be able to detect the
viruses present in clinical samples. High-throughput,
deep sequencing has proven to be an effective tool for
this purpose. The relatively unbiased approach it offers
for screening clinical samples enables virus discovery
without preconceptions about which viruses might be
present in the samples. After 10 years of applying this
technology to virus detection, eukaryotic virus discovery
continues to be robust. A recent example of this is the
novel rhabdovirus, Bas-Congo virus, which is an emerging
pathogen associated with acute hemorrhagic fever [1],
notable for being the first instance of a rhabdovirus being
implicated as a cause of hemorrhagic fever. This virus was
characterized in the context of a small outbreak, and the
presence of antibodies in an asymptomatic caregiver
suggested that person-to-person transmission had
occurred. Another emerging pathogen, human corona-
virus EMC (HCoV-EMC), was recently identified and
characterized following an outbreak in the Middle East
[2]. This betacoronavirus causes symptoms resembling
those of its sister species, SARS coronavirus, including
respiratory symptoms and acute renal failure, although
HCoV-EMC is most closely related taxonomically to bat
coronaviruses. Using modern technologies, the genome of
HCoV-EMC was completely sequenced, and assays have
been developed to monitor its presence. This virus is
particularly interesting because coronaviruses are typi-
cally highly restricted to a specific host, but HCoV-EMC
can infect cells from primates (human and monkey),
swine, and bats (four families) in culture, suggesting that
this virus may utilize a receptor shared among these host
groups and may be readily transmitted between hosts [3].
These and similar studies demonstrate that continued
viral discovery is needed in order to identify and prepare
for the effects of emerging viral pathogens on human
health. The techniques and technologies are in place for
identifying pathogens with similarities to known virusesCurrent Opinion in Microbiology 2013, 16:479–484
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Figure 1
• High-throughput genomic sequencing is an ideal method for
   identifying novel organisms and mutations/reassortants in clinical
   and survey samples without culturing or prior knowledge about
   the virus genome.
Virus discovery and
emerging pathogens
Viruses associated with
diseases of unknown
etiology
• It is important to consider the dynamics and complexity of the
   microbiome, and genomics is a powerful tool for characterizing
   complete microbial communities to initiate and aid these kinds of 
   studies.
Components of the
microbiome interact with
and affect other microbes
• Detailed genomic analysis can be used to identify novel genes for
   further characterization and study.
• Faster sequencing and analysis brings us closer to clinical
   applications of genomic sequencing.
Genome characterization,
gene discovery, and the
future of diagnostic tests
• Many diseases are linked with potential viral causes (Table 2),
   and genomics has great potential for identifying pathogens that
   associate with clinical symptoms, again without the need for
   culturing or the necessity for prior knowledge of the genome.
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The major topics of this review are summarized. Areas of virology research are noted in the blue boxes, and the text in the gray boxes describes how
genomics can be used as a tool in that area of research.(even remote similarities, see Table 1). The availability of
samples and the funding required for the experiments
currently bottleneck virus discovery efforts.
Testing samples from affected individuals during out-
breaks of diseases of unknown etiology is important for
surveillance of pathogens, but it is also important to
identify viruses producing symptoms that are mild or
subclinical because infection with these viruses may
nevertheless have long-term implications for human
health. For example, polyomaviruses and papilloma-
viruses may establish chronic infections. Some of these
viruses, including many alpha papillomaviruses and Mer-
kel cell polyoma virus, are associated with cancer [4–5]. In
light of their capacity to transform cells, identifying the
full range of polyomaviruses and monitoring their pre-
sence could ultimately provide insight into the develop-
ment of some cancers.
Potentially emerging pathogens are of great concern, and
influenza pandemics are of particular interest because
transmissions between animal reservoirs and humans
are observed and the emergence of pandemic strains is
expected. Current molecular technologies allow us toCurrent Opinion in Microbiology 2013, 16:479–484 screen for transmission of influenza between animal
species and between humans, and to evaluate mutations
and quasispecies. In two highly publicized studies,
researchers identified mutations that correlated with air-
borne mammal-to-mammal transmission of the virus, a
trait critical for the development of a pandemic [6,7].
Researchers used either an H5N1 influenza that origi-
nated in birds but had infected humans or a reassortant
virus with the avian subtype H5 hemagglutinin and the
other seven segments from a 2009 pandemic H1N1 virus.
In these studies, viruses were passaged in ferrets, and
isolates that had acquired mutations allowing for airborne
transmission between ferrets were identified. The strains
were sequenced and the mutations that correlated with
ferret-to-ferret transmission were identified. The
mutations were in the host receptor binding protein
hemagglutinin and in the polymerase complex protein
basic polymerase 2, and the studies showed that surpris-
ingly few mutations would be necessary for the virus to
achieve the capacity for airborne transmission between
ferrets. Furthermore, a second study showed that two of
the mutations were already circulating among H5N1
strains in birds [8]. These studies provide valuable insight
into the plausibility of emergence of an H5N1 pandemicwww.sciencedirect.com
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Table 1
Computational tools used to identify viral sequences, including those with remote sequence similarity to known viruses
Software Function References
IDBA-UD, MetaVelvet These programs assemble shorter sequences into longer contiguous
sequences. Longer sequences can help identification of more remote
sequence similarities
[28,29]
BLASTX and TBLASTX A translated nucleotide sequence is queried against a database of protein
sequences or translated nucleotide sequences. This approach is not as
sensitive as the searches involving profile Hidden Markov Models
(HMMs) and iterative searches (described below), but it is sufficient to
identify many viral sequences, including those from many recently
discovered novel viruses.
[30]
Realtime Genomics mapx,
MulticoreWare mblastx,
Rapsearch2
These three programs are like BLASTX but accelerated to accommodate
the large amount of data generated from high-throughput sequencing.
http://www.realtimegenomics.com,
http://www.multicorewareinc.com, [31]
HMMER3 A protein query is used to search a profile Hidden Markov Model (HMM)
database. Jackhmmer is an iterative alignment program that is part of this
package (similar to PSI-BLAST, described below).
[32]
Hhblits A profile HMM is constructed for the query sequence and then used to
query an database of profile HMMs.
[33]
PSI-BLAST Relatively closely related proteins are identified and conserved amino
acid positions are represented in a profile. The profile is used to search a
protein database to identify proteins with more remote homologies. The
new proteins are added to the profile and the search is repeated
iteratively.
[30]
PHI-BLAST A protein and specific pattern within the protein are used to query a
protein database. Proteins that contain the pattern and are similar to the
input protein around the pattern are retrieved. CSI-BLAST performs the
search iteratively.
[34]
DELTA-BLAST Searches a database of profile HMMs and identifies the HMM most
closely related to the query. The resulting HMM is then used to search a
protein database.
[35]strain for which surveillance could be maintained to
anticipate potential outbreaks. It is important to note that
the effects of any mutations on the transmission and
pathogenesis of influenza in humans are regulated by
the genomic context, and the other influenza genes present
may play important roles in promoting or limiting the
spread of a virus in nature. The controversy generated
by this research stemmed from concerns over accidental
release from this laboratory or application of the knowledge
by bioterrorists. These studies sparked heated debate
worldwide, causing some countries to amend their laws
and restrictions for research on pathogens with potential as
agents of bioterrorism [9]. Some argue that tighter restric-
tions will slow research in these areas, potentially leaving us
less protected from coming pandemics.
Viruses associated with diseases of unknown
etiology
There are many diseases of unknown etiology, including
Kawasaki disease and chronic fatigue syndrome that have
attracted efforts to discover a microbial cause (e.g. see
Table 2). XMRV is a retrovirus that was previously associ-
ated with chronic fatigue syndrome and prostate cancer. It
was discovered in prostate cancer samples, and its com-
plete genome was sequenced [10]. Expanded studies of
this virus suggested that it was present in prostate cancer
tissue of 40% of patients with a mutation in the RNase Lwww.sciencedirect.com gene, which encodes an antiviral function, compared to
only 1.5% in prostate cancer patients without the mutation
[10]. A separate study also showed an association of XMRV
with prostate cancers in patients who did not have an
RNase L mutation [11]. Subsequently XMRV was also
associated with chronic fatigue syndrome [12]. However,
these observations were highly controversial, because ot-
her studies found no correlation of XMRV with prostate
cancer, chronic fatigue syndrome, or a plethora of other
diseases of unknown etiologies. The story of this virus has
changed dramatically in the last year as additional studies
showed that XMRV was a laboratory contaminant that
arose from recombination between two proviruses during
the passage of prostate cancer tumor cells through mice
during the development of cell lines [13] and ruled out a
causal relationship between XMRV and prostate cancer
[14]. This story illustrates the caution that must be exer-
cised in the process of virus discovery. Highly sensitive
molecular assays may uncover low-level contaminants as
well as legitimate pathogens, so carefully constructed
controls are critical for accurate interpretation of the data.
Components of the microbiota interact with
and affect other microbes
Interactions of viruses with hosts is not only affected by
the host genotype but may be influenced by the effects of
the bacterial microbiome. This is an area where researchCurrent Opinion in Microbiology 2013, 16:479–484
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Table 2
Diseases of unknown etiology with a suspected viral cause
Disease of unknown etiology Viruses associated Reference (review article)
Kawasaki disease Unknown; many have been examined and ruled out [36]
Multiple sclerosis Epstein Barr virus (EBV); human endogenous retroviruses (HERV) [37–40]
Obesity Human adenoviruses 36, 37 and 5; animal viruses [41,42]
Rheumatoid arthritis EBV and HERV [39]
Systemic lupus erythematosus EBV and HERV [39]
Pityriasis rosea Human herpesvirus 7, possibly human herpesvirus 6; many other
viruses have been examined and ruled out
[43,44]
Amytrophic lateral sclerosis Unknown [45]
Brain tumors Cytomegalovirus (CMV), human 6, herpes simplex viruses 1 and 2 [46]
Inflammatory bowel disease CMV [47]
Bell’s palsy Herpes simplex virus 1 [48]
Inclusion body myositis Retroviruses [49,50]is only beginning, but already interesting observations are
being made. For example, the retrovirus MMTV and
poliovirus have enhanced ability to infect mice in the
presence of gut microbes [15,16]. In the case of MMTV,
the virus uses bacterially derived LPS to subvert the
antiviral response by a mechanism involving the TLR-
4-dependent induction of the immunosuppressive cyto-
kine IL-10 [15]. In the case of poliovirus, gut bacteria
appear to enhance infectivity by promoting virus attach-
ment to host cells [16]. Likewise, depletion of commensal
bacteria in the airways of mice by antibiotic treatment
dampened the immune response to influenza virus, likely
due to the role of commensal bacteria in developing and
regulating the immune system [17]. These studies
suggest that shifts in bacterial communities may be
important considerations when trying to understand the
implications of viral infections for human health. In each
of these cases, mouse models were used, enabling the
controlled comparison of viral infection in genetically
identical mice, which were germ-free, antibiotic-treated,
or colonized with commensal bacteria. Similar studies
correlating viral infections in humans with bacterial com-
munities are important, but much more complicated.
Nonetheless, metagenomic sequencing analyses have
the potential to broadly characterize all of the microbial
organisms present in a clinical sample, a capability that can
be especially powerful when coupled with patient infor-
mation. Ultimately, we may be able to identify bacteria
and viruses that frequently co-occur or are mutually
exclusive and correlate these patterns with clinical symp-
toms and outcomes. This could yield insights into patho-
genesis as well as better diagnostic tools and treatments.
The implications of co-infections are important when
evaluating virus–host interactions. For example, the fla-
vivirus GBV-C has been shown to slow the progression of
HIV to AIDS [18,19], and herpes simplex virus 1 infection
enhances the risk for infection by HIV [20]. Recently,
disease progression of pathogenic SIV infection was
shown to be associated with a major expansion of the
enteric virome [21]. These initial observations wereCurrent Opinion in Microbiology 2013, 16:479–484 made using high-throughput metagenomic sequencing,
which identified at least 32 novel enteric viruses in non-
human primates. Virus infections may compromise the
integrity of the intestinal epithelial lining, allowing the
translocation of immunostimulatory molecules from the
gut into the blood stream with subsequent systemic
immune activation. This study suggests that viruses that
co-infect with SIV may have important roles in the
pathogenesis of the disease. Metagenomic analyses of
samples from people with HIV, sepsis, immunosuppres-
sion from transplants, or even more routine illnesses like
rhinovirus infections, may reveal co-infections that cor-
relate with disease development or symptoms. Recent
PCR-based studies of respiratory samples have found co-
infections with multiple viruses in 12–21.7% of children
with acute respiratory illness [22–24]. In another study,
co-infections were found to be common in patients pre-
senting to the emergency room with fever without a
source, based on metagenomic sequencing [25] and
PCR assays [26], with as many as five viral genera
detected in samples from some subjects [25]. These
studies and others indicate viral co-infections are common
and worthy of further investigation.
Genome characterization, gene discovery,
and the future of diagnostic tests
Genomic sequences of viral strains can be used to predict
viral features that are important for viral replication or
pathogenesis. For example, based on alignment of influ-
enza A virus segment 3 (PA) from >1000 strains, research-
ers recently identified a conserved region that leads to a
pause and ribosomal frame shift during translation [27].
This results in a fusion protein called PA-X consisting of
the N-terminus of the RNA-dependent RNA polymerase
and the newly discovered peptide. This protein appears
to have nuclease activity that dampens the host antiviral
response. What this study illustrates is that comparative
genomics of well-studied viruses can reveal exciting,
novel genomic features with implications for virus repli-
cation, pathogenicity, and interactions with the hosts. In
addition to these kinds of discoveries, the characterizationswww.sciencedirect.com
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with virulence can lead to enhanced diagnostic assays that
provide information that was not previously available to
clinicians. In a new generation of diagnostic tests, rapid
sequencing assays could be used not only to detect viruses
in patient samples but to provide information about the
viral subtype and the presence of virulence genes, which
could be used to predict disease severity and outcome.
Sequence-based diagnostic tests could also be used to
identify the presence of antiviral drug resistance alleles,
which would inform the management of some viral infec-
tions, including influenza A and cytomegalovirus. Further-
more, ultra deep sequencing (resulting in >100–1000
sequences at each base position of the viral gene or
genome) could be used to assess viral variation and qua-
sispecies, which could be important for monitoring emer-
ging pathogens or to development effective vaccines.
Sequencing assays aimed at the human transcriptome also
have the potential to be developed into clinical tests to
measure the host response to viral infection, which may
help both with diagnosis and selection of treatment. An
additional advantage of diagnostic tests based on high
throughput sequencing is that they may be less vulnerable
than PCR-based assays to sequence variation in primer-
binding or probe-binding regions.
Conclusion
Studies of virus–host interactions are firmly supported by
the usage of genome sequencing technologies. A number
of applications and advances that have occurred in the last
two years are described here, but as sequencing becomes
faster and less expensive, the applications to research and
diagnostics expand further. Exploratory sequencing
analyses can be powerful tools to carry out targeted,
hypothesis-driven studies that lead us to better under-
stand pathogenic effects of viruses.
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